How big is the Hemostats Market | Size, Share & Growth 2025

Code: MTA6471 Publication Date: Jul 2025

How big is the Hemostats Market?

According to 6Wresearch internal database and industry insights, Global Hemostats Market was valued at USD 2.6 Billion in 2024 and is expected to reach USD 4 Billion by 2031, growing at a CAGR of 6.40% during the forecast period.

The market is witnessing steady expansion, attributed to increasing surgical interventions, growing trauma and accident cases, and the adoption of advanced wound closure techniques across both hospital and field care settings.

Key Growth Drivers of the Hemostats Market

  • Increase in the number of surgical procedures throughout the world in cardiovascular, orthopedic, and general surgical procedures
  • increased need in minimally invasive procedures where blood loss should be measured accurately
  • Increased awareness of the risks of post-operative bleeding and the requirement of effective hemostatic solutions
  • Innovation of bioactive, thrombin-based, and combination hemostatic products
  • The growing use of hemostats in trauma and military battlefield use

Hemostats Market Trends

The hemostats market is seeing increasing preference for absorbable and active hemostats, which ensure rapid coagulation while minimizing tissue reaction. Manufacturers are developing customizable formats including patches, sprays, and gels tailored to specific surgical specialties. Hospitals are adopting pre-filled, ready-to-use formulations that reduce preparation time in emergency and high-pressure environments. Sustainability concerns are also influencing packaging innovation and bio-based product alternatives.

Emerging Developments in the Hemostats Market

Technological advancement is defining the future of hemostatic agents. Smart hemostats are being designed with the help of nanotechnology and bioengineering and are being made to respond depending upon the type of wound, rate of clotting and stage of healing. Some start-up and medtech entities are already working on X polymer formulation-based synthetic products that are guaranteed to have a sustainable shelf-life and a broad-path clotting profile. Integration with the surgery systems of robot is also picking up, increasing the precision in the cases of complex surgeries.

Major Companies in the Hemostats Market

  • Baxter International Inc.
  • Ethicon Inc. (Johnson & Johnson)
  • B. Braun Melsungen AG
  • Pfizer Inc.
  • Medtronic plc
  • CryoLife Inc.
  • Integra LifeSciences
  • Stryker Corporation
  • Teleflex Incorporated
  • Z-Medica LLC

How big is the Hemostats Market: FAQs

The market is expected to grow at a CAGR of 6.40% between 2025 and 2031.
Bioactive agents, thrombin-based products, and combination hemostats are major contributors.
Rising surgical volumes, trauma and accident cases, demand for minimally invasive procedures, and awareness of post-operative bleeding risks are key growth drivers.
The market faces challenges such as high product costs, regulatory hurdles, and limited shelf life of certain formulations.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All